| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |